The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1.
复制标题
假定的肿瘤抑制因子 miR-1-3p 通过抑制 E2F5 和 PFTK1 来调节前列腺癌细胞的侵袭性
DOI:
10.1186/s13046-018-0895-z
复制
发表时间:
2018-09-05
期刊:
影响因子:
--
通讯作者:
Hu J
中科院分区:
文献类型:
--
作者:
Li SM;Wu HL;Yu X;Tang K;Wang SG;Ye ZQ;Hu J
BackgroundPrevious studies report that miR-1-3p, a member of the microRNA-1 family (miR-1), and functions as a tumor suppressor in several different cancers. However, little is known regarding the biological role and intrinsic regulatory mechanisms of miR-1-3p in prostate cancer (PCa).MethodsIn this study, the expression levels of miR-1-3p were first examined in PCa cell lines and tumor tissues by RT-qPCR and bioinformatics. The in vitro and in vivo functional effect of miR-1-3p was examined further. A luciferase reporter assay was conducted to confirm target associations.ResultsWe found that miR-1-3p was significantly downregulated in advanced PCa tissues and cell lines. Low miR-1-3p levels were strongly associated with aggressive clinicopathological features and poor prognosis in PCa patients. Ectopic expression of miR-1-3p in 22RV1 and LncaP cells was sufficient to prevent tumor cell growth and cell cycle progression in vitro and in vivo. Further mechanistic studies revealed that miR-1-3p could directly target the mRNA 3′- untranslated region (3′- UTR) of two central cell cycle genes, E2F5 and PFTK1, and could suppress their mRNA and protein expression. In addition, knockdown of E2F5 and PFTK1 mimicked the tumor-suppressive effects of miR-1-3p overexpression on PCa progression. Conversely, concomitant knockdown of miR-1-3p and E2F5 and PFTK1 substantially reversed the inhibitory effects of either E2F5 or PFTK1 silencing alone.ConclusionThese data highlight an important role for miR-1-3p in the regulation of proliferation and cell cycle in the molecular etiology of PCa and indicate the potential for miR-1-3p in applications furthering PCa prognostics and therapeutics.
登录
查看更多内容
影响因子:
254.7
作者:
Siegel, Rebecca;Ma, Jiemin;Jemal, Ahmedin
通讯作者:
Jemal, Ahmedin
影响因子:
2
作者:
Luu HN;Lin HY;Sørensen KD;Ogunwobi OO;Kumar N;Chornokur G;Phelan C;Jones D;Kidd L;Batra J;Yamoah K;Berglund A;Rounbehler RJ;Yang M;Lee SH;Kang N;Kim SJ;Park JY;Di Pietro G
通讯作者:
Di Pietro G
影响因子:
64.8
作者:
Denli, AM;Tops, BBJ;Hannon, GJ
通讯作者:
Hannon, GJ
影响因子:
12.4
作者:
Donzelli, S.;Fontemaggi, G.;Blandino, G.
通讯作者:
Blandino, G.
影响因子:
3.4
作者:
Mao, Youjun;Jia, Yuqing;Li, Xiaoqiang
通讯作者:
Li, Xiaoqiang